Regulatory T cells (Tregs) are a subset of CD4 T cells that are key mediators of immune tolerance. Most Tregs develop in the thymus. In this review we summarise recent findings on the role of diverse signalling pathways and downstream transcription factors in thymic Treg development.
Regulatory T Cells: Where Do They Come from and Why Do We Need Them?
The primary function of the mature T cell population is to mediate immune responses against a diverse array of foreign antigens, while remaining unresponsive to self-antigens. While the diversity of the T cell population is generated by the semirandom rearrangement of T cell receptor ( TCR) genes during development in the thymus, tolerance towards self is enforced both in the thymus and periphery known as central and peripheral tolerance, respectively. Fine-tuning the TCR repertoire of the T cell pool during intrathymic development is achieved via two ways: the delivery of survival signals to those cells that successfully ligate their TCRs to MHC molecules loaded with self-peptides with low to moderate affinity (positive selection) and the induction of apoptosis in those that recognise the same ligands strongly enough to be potential mediators of autoimmune disease (negative selection). The latter is aided by the transcription factor Aire (autoimmune regulator) which facilitates the thymic "promiscuous expression" of a diverse array of tissue specific antigens. The remaining cells that fail to recognise self-peptide MHC complexes, such as those which fail to express a mature TCR, undergo time-dependent apoptosis, termed "death by neglect" [1] [2] [3] . The ideal outcome of this stringent and inefficient process of thymic education is a mature T cell repertoire whose TCRs successfully bind self-MHC molecules, while remaining unresponsive to autoantigens. Unfortunately, "central tolerance" to self is incomplete even in healthy mice and humans, in which peripheral T cells with potentially autoreactive TCRs can be found. These cells are kept unresponsive by immune cells whose function is to execute "peripheral" tolerance, with the best studied population being the Foxp3 + CD4 + regulatory T (Treg) cells [4, 5] .
Treg cells were first identified as T cells that express high levels of the surface molecule CD25 and are capable of suppressing autoimmune reactions [4, 6] . Subsequent identification of various surface markers such as the glucocorticoid-induced TNF receptor (GITR), the cytotoxic T lymphocyte antigen 4 (CTLA4), and notably the forkhead box transcription factor Foxp3, which is a Treg-lineage specific transcription factor in mice, allowed further characterisation of these cells [7] [8] [9] . Most Tregs develop in the thymus (tTregs) [10] , with "induced" or "adaptive" Tregs (pTregs for peripherally derived Tregs) generated via diverse mechanisms from naive CD4 T cells [11] also contributing to the peripheral Treg pool. How tTregs, which reach functional maturity within the thymus, are generated has been the subject of considerable scientific debate. Early work with double-transgenic mice expressing a monoclonal TCR and cognate neoautoantigen within the thymus showed a definite skewing of the mature thymic CD4SP population towards a CD25
+ Foxp3 + regulatory phenotype [12] [13] [14] , in a TCR affinity-dependent manner [13] . These data and similar subsequent work were the basis of the prevailing hypothesis that developing thymocytes are directed down the tTreg lineage by high-affinity TCR interactions with thymic peptide: MHC complexes [15] .
Role of TCR, CD28, and IL-2R Signalling in Thymic Treg Development
While there are a number of unreconciled observations in the literature, objective data regarding discrete developmental steps prior to the appearance of Foxp3-expressing mature tTreg cells have emerged. A recent report has identified at least two distinct phases in tTreg development, based upon differential dependence on TCR signals [16] . They identified a Foxp3 − population (tTreg precursors) and demonstrated that it was enriched for tTreg-specific TCRs-indicating prior selection on the basis of TCR-and required only common-chain ( ) cytokines (predominantly IL-2) to differentiate into mature, Foxp3-expressing tTreg cells. Based on these observations the "two-step" model of tTreg cell development was proposed. In the first step, thymocytes undergo TCR and coreceptor dependent selection that gives rise to the CD4 + CD25 + GITR hi Foxp3 − tTreg precursors [17, 18] . A subsequent TCR-independent IL-2/IL-15 dependent step results in Foxp3 expression marking the differentiation of tTreg precursors into tTregs [16, 19] . This two-step model is the currently prevailing framework through which thymic tTreg development is analysed (Figure 1) .
TCR ligation eventually leads to activation of the transcription factors NF-AT and NF-B [20, 21] . The activation of NF-AT depends on its dephosphorylation by the Ca 2+ dependent phosphatase Calcineurin [22] . Although, both NF-AT and Calcineurin pathways have been implicated in tTreg development, their precise role in this process is controversial [23] [24] [25] . The redundant function of different NF-AT isoforms expressed in T lineage cells has made it difficult to ascertain the role of this group of transcription factors in tTreg development. NF-AT is required for the induction of Foxp3 transcription in vitro [26, 27] . However, thymic regulatory T cell development and function are relatively normal in NF-ATc1/NF-ATc4 double deficient mice [28] , with the suggestion that NF-ATc2 may compensate for the lack of NF-ATc1 and NF-ATc4 in these animals. Notably, mice deficient for NF-ATc2 and NF-ATc3 also exhibit normal tTreg development [29] . A severe defect in CD4 SP development due to a lack of NF-AT and ERK activation pose significant challenges to the study of Treg development in CalcinuerinB1 deficient mice [30] [31] [32] . Therefore, based on current experimental evidence, the Calcineurin/NF-AT pathway appears to be largely redundant in Treg development in the thymus. The apparent inconsistency between the requirement of NF-AT for Foxp3 expression in vitro (discussed later) and redundant function in tTreg development is further complicated by the finding that Calcineurin is not required for constitutive nuclear localisation of NF-AT in Tregs [33] .
A number of reports have described a role for NF-B in tTreg development [23, [34] [35] [36] [37] . TCR dependent activation of NF-B is mediated by a scaffold protein CARMA1, which belongs to the family of membrane associated guanylate kinases (MAGUK) [38] [39] [40] . TCR ligation leads to the calcium dependent activation of PKC , which in turn phosphorylates CARMA1 resulting in the recruitment of Bcl10 and MALT1. The CARMA1/Bcl10/MALT1 trimer, also known as the CBM complex, acts as a signalling platform that recruits and activates the IKK (I B kinase) complex, ultimately resulting in NF-B activation [41] [42] [43] . The Rel/NF-B family of transcription factors is comprised of 5 members, NF-B1, NF-B2, RelA, RelB, and c-Rel. Homo-and heterodimers of Rel/NF-B proteins exist as latent complexes bound to I B (inhibitor of B) proteins in the cytosol. Signals emanating from diverse cell surface receptors including the TCR result in IKK dependent phosphorylation of I B, targeting it for ubiquitin-dependent proteasome-mediated degradation, thereby allowing NF-B dimers to enter the nucleus and bind to decameric B sites on regulatory elements of various genes [44, 45] . NF-B regulated gene expression impinges on diverse processes downstream of the TCR including T cell development, survival, and cytokine production [46] . Given such functional diversity displayed by NF-B in CD4 T cell development/activation, it is not surprising that it plays a role in tTreg development. Mice deficient in PKC [23, 37] or CARMA1 [34, 35] or those that lack Bcl10 [37] exhibit significant reduction in tTregs. A conditional deletion of in DP thymocytes also results in loss of tTregs [36] . tTreg development has also been studied in some individual NF-B knockout mice. While tTreg numbers are relatively normal Clinical and Developmental Immunology 3 in NF-B1 −/− mice [18] , the absence of RelA results in a 2-fold reduction in thymic CD4 + CD25 + Foxp3 + cells [47] . Of all the NF-B family members, c-Rel is the most important player in tTreg development with a ∼6-10 fold reduction in tTreg numbers in C-rel −/− mice [18, [47] [48] [49] [50] [51] . It is important to note that like CARMA1, c-Rel also plays a nonredundant cell intrinsic role in the development of tTreg precursors [18, 35, 52] . It is believed that both CARMA1 and c-Rel deficient Treg precursors have impaired IL-2R signaling [53, 54] and as a consequence fail to efficiently differentiate into Foxp3 + tTregs in response to IL-2 [52] .
Signalling downstream of CD28 synergises with TCR signals to promote optimal Treg development [55] . Although the role of CD28 signalling in peripheral homeostasis and survival of Tregs is well appreciated [56] [57] [58] , the precise mechanism by which costimulatory signals regulate tTreg development is poorly understood. Interaction of B7 with CD28 is believed to strengthen contact between the antigen presenting cell and developing thymocyte thereby promoting survival of the latter via IL-2 production and upregulation of prosurvival Bcl XL [59] [60] [61] . Both CD28 and B7 knockout mice have significant reduction in thymic Treg numbers [18, 55, 57, 58 ]. An elegant study by Tai et al. described a PYAP motif (aa 187-190) in the cytoplasmic tail of CD28 that is required for tTreg development. Apart from binding the tyrosine kinase Lck, this motif is also required for IL-2 production. Although transgenic overexpression of a wild-type CD28 transgene significantly rescued tTreg numbers in Cd28 −/− mice, a mutant CD28 transgene where both Prolines in the PYAP motif were substituted with Alanine failed to do so [55] . Recent work has demonstrated that CD28 is also required for the generation of tTreg precursors. Using mixed bone marrow chimeras, a cell intrinsic role of CD28/Lck in development of tTreg precursors was described [18] . The requirement of Lck in CD28 dependent tTreg development is not restricted to generation of tTreg precursors as Lck activation is also required for expression and stabilisation of Foxp3 message [62] . Interestingly, IL-2 deficiency in mice has little to no impact on tTreg numbers [63, 64] . However, IL-2 plays an important role in the survival of mature Tregs [63, 64] .
Transcriptional Control of foxp3 in Thymic Tregs
Humans with a mutation in their foxp3 gene suffer from a spontaneous inflammatory disease called IPEX [65] [66] [67] (Immune dysregulation Polyendocrinopathy Enteropathy X linked syndrome). Additionally, a naturally occurring Foxp3 mutation in mice (Scurfy) results in a severe T cell dependent multiorgan autoimmune and inflammatory disease [68, 69] . These findings necessitated closer examination of how the expression of this crucial transcription factor is controlled. The architecture of the Foxp3 promoter along with its downstream cis regulatory elements determines Treg-specific expression and maintenance of Foxp3. The promoter of Foxp3 is located ∼6.6 kb upstream of its translational start site and has weak transcriptional activity [70] which is enhanced by the binding of several transcription factors (TFs) to the cis regulatory elements located in the introns. Two evolutionarily conserved noncoding sequences (CNS), Cns1 and Cns2, located in the first intron between the two 5 UTR exons act as enhancer elements [70] . Additionally, an enhancer element, Cns3, located in the third intron immediately after the first coding exon serves an indispensable role in the induction of Foxp3 expression during thymic Treg development [50] . The importance of these CNSs in Foxp3 expression and Treg development was demonstrated by systematic deletion of these cis acting elements in mice [50] . Cns1 was shown to be dispensable for tTreg development but required for TGF dependent conversion of naive CD4 + T cells into Tregs.
Cns2
−/− mice did not display major defects in thymic Treg development. However, Cns2 deletion adversely affected the stability of Foxp3 expression. In contrast, deletion of Cns3 resulted in a significant reduction in thymic Treg numbers. TCR, CD28, and IL-2 dependent signals activate and recruit TFs to the promoter and Cns2 and Cns3 enhancer elements to initiate Foxp3 transcription and maintain stable expression of Foxp3 in tTregs. These enhancer regions are also amenable to epigenetic modifications, which serve as an additional layer of transcriptional control imposed on Foxp3 expression.
Differential DNA Methylation Regulates foxp3 Transcription
The Cns2 element encompasses a CpG island that is hypomethylated only in thymic Tregs [48] . TCR signals result in Cns2 demethylation rendering this element permissive for the binding of transcription factors induced downstream of TCR, CD28, and the IL-2R [70] [71] [72] [73] . Pharmacological inhibition of DNA methylation resulted in Foxp3 induction in conventional CD4 + T cells [74] supporting the notion that methylation of Cns2 is prohibitive for Foxp3 expression. Conversely, reducing the expression of the DNA methyltransferase, Dnmt1, using shRNA mediated knockdown also resulted in Foxp3 expression, reinforcing the importance of Cns2 demethylation in thymic Treg development [70] . In addition to the induction of Foxp3 transcription, demethylation of Cns2 is also required for stable Foxp3 expression [50] . Although forced demethylation of Cns2 is known to initiate Foxp3 transcription, the exact TCR dependent mechanism(s) that demethylates Cns2 during tTreg development is unclear. It is important to appreciate that the exact role of Cns2 is hard to define in the absence of further knowledge about factors that bind this region. The lack of a phenotype in Cns2 −/− mice may mean that Foxp3 expression proceeds unimpeded because a negative regulatory region (Cns2) is no longer there. In other words, the function of Cns2 demethylating factors is made redundant in Cns2 −/− mice. Like Cns2, the Foxp3 promoter region has interspersed CpG motifs the methylation status of which is critical for the initiation of transcription. The Foxp3 promoter region is completely methylated in naive CD4 T cells and partially methylated in Tregs [70, 74] . However, unlike Cns2, promoter demethylation increases as Tregs mature and migrate to the periphery [75, 76] . Like Cns2, demethylation of the promoter is permissive for the binding of several TFs to initiate the expression of Foxp3 in response to TCR, CD28, and IL-2R signals. Supporting this notion, a negative regulator of Treg development PIAS1 maintains the Foxp3 promoter in its methylated state by binding to it and recruiting DNA methyltransferases and Heterochromatin protein 1 resulting in the formation of a "repressive complex" [77] . This "repressive complex" collapses upon TCR signalling and the promoter becomes accessible to TFs to participate in the initiation of transcription [77] .
TCR-and IL-2-Induced Transcription Factors Induce Foxp3 Expression in tTregs
Several TFs have been implicated as essential factors in Foxp3 expression. Primarily the NF-B family member, c-Rel, has been demonstrated to be important in Foxp3 induction during tTreg development. The drastic reduction of tTreg numbers in C-rel −/− mice is linked to a defect in the induction of Foxp3 expression [48] . To date, three different mechanisms have been proposed to explain the role of c-Rel in Foxp3 induction. Given TCR signalling is responsible for Cns2 demethylation with c-Rel being activated downstream of the TCR, it is possible that recruitment of c-Rel to Cns2 results in its demethylation [48] . This hypothesis stems from the finding that c-Rel can bind to the methylated Cns2 region in the Foxp3 locus [48] . Therefore, it is plausible that demethylation of The demethylated Cns2 region also recruits cyclic-AMP response element binding protein (CREB)/activating transcription factor (ATF) in response to TCR signals [70] . Another group of proteins known to induce Foxp3 expression in tTregs belong to the Foxo family of TFs and include Foxo1 and Foxo3 that bind to the promoter and Cns2 elements to induce Foxp3 expression. [78] . TCR and CD28 stimulation results in activation and nuclear entry of c-Rel. In contrast, Foxo protein that are constitutively present in the nucleus are phosphorylated and inactivated by the PI3K/Akt signalling axis downstream of TCR. Therefore it is possible that Foxo proteins and c-Rel bind sequentially to the Foxp3 locus [78] . In addition to these transcription factors, IL-2-induced STAT5 also has a prominent role in controlling Foxp3 expression [71] [72] [73] . IL-2 signalling induces increased levels of SOCS1, which negatively regulates STAT5 resulting in reduced Foxp3 expression. Therefore, efficient expression of Foxp3 requires suppression of SOCS1 levels in Tregs. The microRNA mIR155 targets Socs1 mRNA in Tregs and consequently maintains high levels of STAT5 expression [79] . Deletion of Mir155 in mice has been reported to result in upregulation of SOCS1 and subsequent inhibition of STAT5 mediated Foxp3 expression in tTregs [79, 80] . Sustained or stable expression of Foxp3 which is critical for tTreg-lineage stability is maintained by the TFs, Runx1, and Cbf . These TFs form a trimeric complex with Foxp3 and bind Cns2 establishing a feed forward loop ensuring stable Foxp3 expression [50] . Given these findings, we propose that c-Rel, known as the "pioneer TF, " is the first TF to bind to the Foxp3 promoter, Cns3, and Cns2 following TCR ligation. The binding of c-Rel to Cns3 and methylated Cns2 results in demethylation of Cns2 facilitating subsequent recruitment of Foxo1 and Foxo3. Phospho-STAT5 induced by IL-2 follows soon after ultimately resulting in Foxp3 transcription. It is important to note that once demethylated, the Cns2 CpG region is protected from methylating enzymes by the Foxp3-Runx1-Cbf complex [50] . In summary, we propose that the TCR-/IL-2-induced transcriptional activation of Foxp3 is initiated by c-Rel, which is then maintained by sequential binding of other TFs including Foxp3 itself (Figure 2 ).
Concluding Remarks
Since their discovery, regulatory T cells have been at the forefront of immunology research. Although we have made significant progress towards the understanding of their development and function a lot needs to be done to apply these findings in the clinic. Although a number of publications have reported modulation of Treg numbers and/or function in diverse disease, very little is known about the real impact of Treg modulation in disease onset and progression. It is critical to acknowledge that Tregs can be both beneficial and deleterious depending on the disease and stage. Therefore we believe that a careful analysis of Treg function in individual diseases is needed to meaningfully apply Treg based therapies in the clinic.
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